In Vivo Calcium Imaging of Cortical Microcircuits in Huntington's Disease Mice

Neuronal activity data from premanifest Hdh150 knock-in mice, used to study early Huntington's disease. The research assessed circuit dysregulation in the visual cortex and the effects of metformin treatment. Specific row counts and column details are not provided.

Use Cases

• Analyze patterns of neuronal hyperactivity and synchronicity in the visual cortex from in vivo calcium imaging.
• Correlate cortical network activity changes with behavioral aberrations in premanifest disease models.
• Assess the impact of metformin treatment on aberrant Huntingtin protein load and network activity restoration.
• Identify hyperactive neurons within microcircuits as potential early biomarkers for Huntington's disease.

Strengths

• Data originates from a peer-reviewed study published in 2020, providing scientific context.
• Focuses on the critical 'very far from disease onset' (VFDO) stage in Huntington's disease research.
• Includes multi-modal data linking in vivo calcium imaging findings with behavioral observations.

Limitations

• Sample size and specific data dimensions (rows, columns) are unknown, limiting assessment of statistical power.
• Data is derived from a specific mouse model (Hdh150 knock-in), which may not fully translate to human disease.
• Temporal coverage and the number of experimental subjects or trials are not specified.

Provenance

Source

Isabelle Arnoux

Collection Method

In vivo two-photon Ca2+ imaging in premanifest Hdh150 knock-in mice, accompanied by behavioral assessment.

Freshness

2020-06-30